An application made for this job — a tailored resume and cover letter that speak straight to the posting.
Hemab Therapeutics is seeking a Scientist, PK/PD Modeling & Simulation to develop population PK/PD, exposure–response, and QSP models for model-informed drug development across its pipeline.
You will collaborate with clinical pharmacology, nonclinical, clinical development, biometrics, regulatory and quality teams to deliver quantitative insights for dose selection, study design, and regulatory filings, advancing Hemab’s mission.
Join Hemab, a clinical-stage biotech company, on an exciting journey to build the ultimate clotting company. We focus on addressing the high unmet needs of patients suffering from rare bleeding and thrombotic disorders. With offices in Cambridge, MA, USA, and Copenhagen, Denmark, Hemab cultivates a vibrant, agile and forward-thinking environment where collaboration, innovation, and high-quality biotherapeutics development go hand in hand.
As a Scientist, PK/PD Modeling & Simulation, you will be responsible for developing, validating, and applying population PK, PK/PD, exposure–response and QSP models to support model-informed drug development across Hemab’s pipeline. You will work closely with internal cross-functional leads (clinical pharmacology, nonclinical, clinical development, biometrics, regulatory and quality) and external collaborators (CROs and consultants) to provide quantitative insights that inform dose selection, clinical study design, and regulatory filings. Your work will be central to integrating modeling and simulation strategies into Hemab’s clinical programs and advancing our mission to deliver first-in-class therapies to patients with rare bleeding disorders.
At Hemab, we foster an environment where everyone can wear multiple hats depending on their experience, fit, and motivation to get things done. We constantly strive to celebrate our achievements collectively and gather feedback to continuously sustain and improve our fast-paced, cross-functional work environment.